These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 28388745)

  • 1. [Intensive Care of Hematological and Oncological Patients: Recent Challenges].
    Beutel G; Schellongowski P; Kiehl M; Kochanek M
    Dtsch Med Wochenschr; 2017 Apr; 142(7):500-505. PubMed ID: 28388745
    [No Abstract]   [Full Text] [Related]  

  • 2. [Infections in hemato-oncology patients in intensive care. An interdisciplinary challenge].
    Kochanek M; von Bergwelt-Baildon M; Shimabukuro-Vornhagen A
    Med Klin Intensivmed Notfmed; 2013 Apr; 108(3):197-202. PubMed ID: 23525488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive care of haematological patients.
    Magid T; Haase N; Andersen JS; Nielsen OJ; Bonde J
    Dan Med J; 2012 Mar; 59(3):A4395. PubMed ID: 22381090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients.
    Lengliné E; Chevret S; Moreau AS; Pène F; Blot F; Bourhis JH; Buzyn A; Schlemmer B; Socié G; Azoulay E
    Bone Marrow Transplant; 2015 Jun; 50(6):840-5. PubMed ID: 25798675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urgent chemotherapy in hematological patients in the ICU.
    Moors I; Pène F; Lengline É; Benoit D
    Curr Opin Crit Care; 2015 Dec; 21(6):559-68. PubMed ID: 26539930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ICU and 6-month outcome of oncology patients in the intensive care unit.
    McGrath S; Chatterjee F; Whiteley C; Ostermann M
    QJM; 2010 Jun; 103(6):397-403. PubMed ID: 20231238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preempting critical care services for patients with hematological malignancies.
    Azoulay É; Soares M; Lengliné É
    Intensive Care Med; 2021 Oct; 47(10):1140-1143. PubMed ID: 34519846
    [No Abstract]   [Full Text] [Related]  

  • 8. Should we admit patients with haematological malignancy to intensive care?
    Jones C; Hewson R; Ramessur S
    Br J Hosp Med (Lond); 2009 Sep; 70(9):544. PubMed ID: 19749653
    [No Abstract]   [Full Text] [Related]  

  • 9. [Elderly with hematological neoplastic disorders: actions and difficulties related to self-care at the beginning of the disease].
    Rusisca-de Toledo EH; Diogo MJ
    Rev Lat Am Enfermagem; 2003; 11(6):707-12. PubMed ID: 15042195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of Clinical Deterioration in Hospitalized Adult Patients with Hematologic Malignancies Using a Neural Network Model.
    Hu SB; Wong DJ; Correa A; Li N; Deng JC
    PLoS One; 2016; 11(8):e0161401. PubMed ID: 27532679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemato-oncology patients in acute respiratory failure in the ICU].
    Ben-Abraham R; Segal E; Hardan I; Shpilberg D; Stemer S; Shitrit A; Ben-Bassat I; Perel A
    Harefuah; 1997 Aug; 133(3-4):91-4, 167. PubMed ID: 9332070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and utility of scoring systems in patients with hematological malignancies admitted to the intensive care unit and required a mechanical ventilator.
    Nishida K; Palalay MP
    Hawaii Med J; 2008 Oct; 67(10):264-9. PubMed ID: 19097551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. End-of-life care for hematological malignancies: the 'technological imperative' and palliative care.
    McGrath P
    J Palliat Care; 2002; 18(1):39-47. PubMed ID: 12001402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA polymorphisms as markers of risk, prognosis and treatment response in hematological malignancies.
    Dzikiewicz-Krawczyk A
    Crit Rev Oncol Hematol; 2015 Jan; 93(1):1-17. PubMed ID: 25217091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent publications in hematological oncology.
    Hematol Oncol; 2000 Dec; 18(4):161-168. PubMed ID: 11135357
    [No Abstract]   [Full Text] [Related]  

  • 16. Is there really a need for anti-coagulant prophylaxis for CVC-related thrombotic complications in pediatric oncological-hematological diseases?
    Cesaro S; Corrò R; Gamba P; Zanon GF
    Support Care Cancer; 2002 Apr; 10(3):258-9; author reply 260-1. PubMed ID: 11904793
    [No Abstract]   [Full Text] [Related]  

  • 17. [The progress of targeted therapy of hematological malignancies in recent 10 years].
    Wang L; Shen ZX
    Zhonghua Nei Ke Za Zhi; 2013 Feb; 52(2):121-3. PubMed ID: 23967604
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognosis-related factors in intensive care unit (ICU) patients with hematological malignancies: A retrospective cohort analysis in a Chinese population.
    Liu J; Cheng Q; Yang Q; Li X; Shen X; Zhang L; Liu Z; Khoshnood K
    Hematology; 2015 Oct; 20(9):494-503. PubMed ID: 25585045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hematologic and oncologic emergencies].
    von Bergwelt-Baildon M; Böll B; Shimabukuro-Vornhagen A; Kochanek M
    Med Klin Intensivmed Notfmed; 2013 Apr; 108(3):184-90. PubMed ID: 23455441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dying from hematological cancers.
    Enck RE
    Am J Hosp Palliat Care; 2002; 19(2):79-80. PubMed ID: 11926447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.